FDA Clears OTC Glucose Monitoring System for Weight Management

Follow Drugslib on

By Stephanie Brown HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, Aug. 22, 2025 -- The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight management.

Signos integrates the Stelo by Dexcom glucose biosensor with an artificial intelligence-driven platform to show how food, activity, stress, sleep, and timing affect the body in real time -- empowering people to make personalized, biology-backed health decisions.

Key features of the monitoring system include personalized metabolic guidance that uses the body's own signals and artificial intelligence-driven insights to help users improve sleep, manage weight, and lower chronic disease risk. The system translates real-time glucose fluctuations into simple, personalized recommendations for healthier daily habits and tracks and connects responses to meals, exercise, sleep, and stress.

Customers can subscribe to Signos with a three-month plan for $139 per month or a six-month plan for $129 per month. The company provides all necessary continuous glucose monitors for the chosen plan duration.

According to the U.S. Centers for Disease Control and Prevention, 73.6 percent of U.S. adults are classified as having overweight or obesity. With the results of the Global Burden of Disease Study 2021 projecting diabetes diagnoses will reach 1.3 billion by 2050, the scale of the metabolic health crisis is rapidly accelerating.

"This is more than a product launch -- it's a mission," Sharam Fouladgar-Mercer, CEO and founder of Signos, said in a statement. "Everyone deserves access to insights that help them live healthier, longer, more vibrant lives. Signos isn't just about data; it's about giving people ownership over their health and weight journeys in a way never before seen."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-23 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords